Juyao Dong Selected Research

Intravenous Injections

10/2015

Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juyao Dong Research Topics

Disease

3	Neoplasms (Cancer) 01/2017 - 11/2013
1	Ovarian Epithelial Carcinoma 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Infections 01/2017
1	Inflammation (Inflammations) 09/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2015
1	Pneumonia (Pneumonitis) 09/2015
1	Nephrogenic Fibrosing Dermopathy 02/2014
1	Fibrosis (Cirrhosis) 02/2014
1	Pneumoconiosis 02/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2013

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2017 - 11/2013
2	Small Interfering RNA (siRNA)IBA 01/2017 - 10/2015
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 10/2015
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2015 - 09/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Therapeutic UsesIBA 10/2015
1	silanolIBA 09/2015
1	Siloxanes (Siloxane)IBA 09/2015
1	CytokinesIBA 09/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015
1	Contrast MediaIBA 02/2014
1	GadoliniumIBA 02/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2014
1	Biological ProductsIBA 11/2013
1	Gemcitabine FDA Link 11/2013
1	Liposomes (Liposome)IBA 11/2013

Therapy/Procedure

1	Intravenous Injections 10/2015
1	Therapeutics 11/2013